Cellect Biotechnology Ltd. (APOP)

0.8834 -0.0189 (-2.095%)

IEX Real-Time Price

April 25, 2019 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.9023

Price Open 0.8998

Volume: 25,923

Avg Volume: 180,140

Market Cap: 5.76M

P/E Ratio -1.02

52 Wk Range 0.8505-7.8



APOP Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
6.51M
43,387
5.45
0.67%

2018-09-28
6.51M
49,843
5.95
0.77%

2018-09-14
6.51M
50,090
2.70
0.77%

2018-08-31
6.51M
44,635
1.65
0.69%




APOP Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2019-03-18
Q4 2018
N/A
0.00 (0)
-0.16
0.00

2018-11-13
Q3 2018
N/A
-0.28 (1)
-0.29
-0.01

2018-08-09
Q2 2018
N/A
-0.29 (1)
-0.26
0.03

2018-06-04
Q1 2018
N/A
-0.30 (1)
0.00
0.00

News

Cellect Bio up 17% premarket on positive ApoGraft data (2019-03-27 08:29 SeekingAlpha)

Thinly traded nano cap Cellect Biotechnology (NASDAQ: APOP ) is up 17% premarket on modestly higher volume in reaction to positive preliminary results from a Phase 1/2 clinical trial evaluating its ApoGraft stem cell selection technology in patients undergoing stem cell transpl…

 

Cellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft(TM) Technology (2019-03-27 08:00 PR Newswire)

TEL AVIV, Israel , March 27, 2019 /PRNewswire/ --Further validating its ApoGrafttechnology, Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced positive mid-study data from the Company's Phase I/II study of its A…

 


Statistics

Shares Outstanding: 6.52M

Top 15 Institution Percent: 2.10

Price To Sales: N/A

Price To Book: 1.49

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -77.47

Return On Equity: -120.65

Profit Margin: N/A

Price History

Beta: 2.32

50-day Moving Avg: 1.01

200-day Moving Avg: 3.57

YTD Change: -60.94

5-day Change: 3.12

1-month Change: -5.02

3-month Change: -66.58

6-month Change: -80.96

1-year Change: -86.75

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Cellect Biotechnology Ltd.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.cellect.co

Cellect Biotechnology Ltd is an emerging biotechnology company engaged in developing a novel technology platform known as ApoGraft that selects stem cells in order to improve the safety and efficacy of regenerative medicine and stem cell therapies.